Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 11/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 6/20 | 0.43 |
| ▸ | PPARA | Q07869 | 6/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29893958 | 1.00 | GPR84 (0.59) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL6463301 | 1.00 | GPR84 (0.59) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL29894891 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL6463845 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL1158455 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL6465804 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL28499460 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL6466759 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL6461561 | 0.98 | GPR84 (0.62) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL6461000 | 0.93 | GPR84 (0.50) | GPR84FFAR1FFAR4PPARDAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120117984-A | Preparation method of 6-hydroxy-8-chlorooctanoate | 江西联陆生物科技有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| EP-2125031-B1 | LIPIDS AND LIPID ASSEMBLIES COMPRISING TRANSFECTION ENHANCER ELEMENTS | MARINA BIOTECH INC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-8193246-B2 | Lipids and lipid assemblies comprising transfection enhancer elements | MARINA BIOTECH, INC. (US) | 2012-06-05 | — | — | US | disclosed |
| EP-2125031-A2 | LIPIDS AND LIPID ASSEMBLIES COMPRISING TRANSFECTION ENHANCER ELEMENTS | Novosom AG (DE) | 2009-12-02 | — | — | EP | disclosed |
| US-20080306153-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | CEQUENT PHARMACEUTICALS, INC. | 2008-12-11 | — | — | US | disclosed |
| WO-2008074487-A2 | LIPIDS AND LIPID ASSEMBLIES COMPRISING TRANSFECTION ENHANCER ELEMENTS | NOVOSOM AG (DE) | 2008-06-26 | — | — | WO | disclosed |
| US-6903233-B2 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1367067-A1 | Highly water-absorptive ophthalmic lens and method of producing the same | Menicon Co., Ltd. (JP) | 2003-12-03 | — | — | EP | disclosed |
| US-20030218717-A1 | Highly water-absorptive ophthalmic lens and method of producing the same | MENICON CO., LTD. (JP) | 2003-11-27 | — | — | US | disclosed |
| EP-1344763-A1 | Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters | Takasago International Corporation (JP) | 2003-09-17 | — | — | EP | disclosed |
| EP-0799830-B1 | Imidazothiazol derivatives as components of liquid crystalline mixtures | ROLIC AG (CH) | 2002-05-29 | — | — | EP | disclosed |
| US-5851425-A | Imidazothiazoles | ROLIC AG (CH) | 1998-12-22 | — | — | US | disclosed |
| EP-0799830-A1 | Imidazothiazol derivatives as components of liquid crystalline mixtures | Rolic AG (CH) | 1997-10-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | HDHD5, APEH, AOC3 | GPR84 3209/4885FFAR1 349/4885FFAR4 507/4885 |
| US-20080306153-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | SREBF1, SREBF2, ELOVL1 | GPR84 3559/4885FFAR1 1005/4885FFAR4 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.